Vertex Pharmaceuticals Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, Vertex Pharmaceuticals Inc. reported total assets of $25.64B and shareholders' equity of $18.67B. That works out to liabilities equal to 27% of assets, a current ratio of 2.90 (current assets ÷ current liabilities).
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.90B | $3.55B | $6.25B | $8.32B | $11.75B | $13.43B | $18.15B | $22.73B | $22.53B | $25.64B |
| Current assets | $1.83B | $2.65B | $3.84B | $4.82B | $8.13B | $9.56B | $13.23B | $14.14B | $9.60B | $11.20B |
| Cash & equivalents | $1.18B | $1.67B | $2.65B | $3.11B | $5.99B | $6.79B | $10.50B | $10.37B | $4.57B | $5.08B |
| Total liabilities | $1.56B | $1.50B | $1.81B | $2.23B | $3.06B | $3.33B | $4.24B | $5.15B | $6.12B | $6.98B |
| Current liabilities | $792.54M | $807.26M | $1.12B | $1.33B | $1.88B | $2.14B | $2.74B | $3.55B | $3.56B | $3.86B |
| Shareholders' equity | $1.16B | $2.03B | $4.44B | $6.09B | $8.69B | $10.10B | $13.91B | $17.58B | $16.41B | $18.67B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 875320 (raw data). Most recent filing in this dataset: 10-Q filed Nov 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.